Drawing for BIOBOND

USPTO serial 99453904

BIOBOND

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
RODRIGUEZ FONTANE, KIARA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOBOND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vanessa Backman

149 Commonwealth Drive, Suite 1042Menlo Park, CA 94025United States

Goods and services

ClassDescriptionStatusFirst use
003Oil baths for hair care; Roller bottles sold filled with essential oils; Nutritional oils for cosmetic purposes; Toiletry bags sold filled with non-medicated toiletry preparations, namely, Soap,Liquid hand soap,Body wash,Face wash,Face cleanser,Shampoo,Hair conditioner,Makeup remover oil,Makeup remover wipes and Makeup remover lotion; Massage oil; Essential oils for aromatherapy use; Body oils; Aromatic essential oils; Anti-aging moisturizer; Anti-aging moisturizers used as cosmetics; Skin and body topical lotions, creams and oils for cosmetic use; Skin cleansing lotion; Non-medicated skin creams with essential oils for use in aromatherapy; Hand cream; Face and body creams; Eye cream; Non-medicated hair serums; Non-medicated facial and eye serum containing antioxidants; Non-medicated anti-aging serum; Beauty serumsACTIVEFeb 4, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 2, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 9, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 7, 2026IUAFUSE AMENDMENT FILED—
Aug 6, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 4, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 9, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 14, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 21, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance